Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kidsolite
- Development stage
- Unknown
- Lead developer
- Spey Medical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Kidsolite is an oral pediatric gripe water formulation developed and marketed by SPEY to relieve gastrointestinal discomfort, infantile colic, flatulence, and indigestion in infants and children. It is a fixed-dose combination containing sodium bicarbonate (Sajjikhar), dill oil (*Anethum sowa*), and ginger oleoresin (*Zingiber officinale*). Sodium bicarbonate acts as an antacid to neutralize excess stomach acid, while dill oil and ginger oleoresin serve as carminatives and antispasmodics that relax the smooth muscles of the digestive tract, helping to ease trapped gas and reduce intestinal spasms.
- Brand names
- KidsoliteKidsolite Syrup
02
Targets
HCl (Hydrochloric acid)
Beyond the preview
Go deeper on Kidsolite.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kidsolite.